Organogenesis Holdings Inc.
ORGO
$4.97
$0.1453.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -22.62% | -21.17% | 27.10% | 6.12% | 11.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -22.44% | -21.17% | 27.10% | 6.12% | 11.01% |
| Cost of Revenue | -5.37% | -17.33% | 11.82% | 3.90% | 10.95% |
| Gross Profit | -27.38% | -22.53% | 33.00% | 6.82% | 11.03% |
| SG&A Expenses | -3.57% | 0.26% | 24.20% | 11.96% | 8.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.82% | -6.11% | 17.61% | 8.52% | 12.65% |
| Operating Income | -221.56% | -423.86% | 1,474.58% | -23.36% | -7.38% |
| Income Before Tax | 18.61% | -493.67% | 670.88% | -23.75% | -258.41% |
| Income Tax Expenses | -197.56% | -209.41% | 310.10% | -245.59% | -35.21% |
| Earnings from Continuing Operations | 44.89% | -797.29% | 1,450.88% | 289.36% | -420.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.89% | -797.29% | 1,450.88% | 289.36% | -420.60% |
| EBIT | -221.56% | -423.86% | 1,474.58% | -23.36% | -7.38% |
| EBITDA | -147.72% | -13,234.71% | 201.75% | -10.67% | 0.25% |
| EPS Basic | 25.19% | -975.47% | 1,153.49% | 285.89% | -417.53% |
| Normalized Basic EPS | -227.76% | -361.65% | 8,133.33% | -25.27% | -9.74% |
| EPS Diluted | 25.19% | -755.00% | 1,032.56% | 350.00% | -421.50% |
| Normalized Diluted EPS | -227.76% | -361.65% | 7,983.33% | -24.86% | -8.47% |
| Average Basic Shares Outstanding | -4.31% | -4.22% | -0.95% | 0.96% | 0.97% |
| Average Diluted Shares Outstanding | -4.31% | -4.22% | 0.23% | 0.38% | -0.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |